These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25919234)

  • 1. Ovarian response biomarkers: physiology and performance.
    Iliodromiti S; Nelson SM
    Curr Opin Obstet Gynecol; 2015 Jun; 27(3):182-6. PubMed ID: 25919234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
    Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
    Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technical and performance characteristics of anti-Müllerian hormone and antral follicle count as biomarkers of ovarian response.
    Iliodromiti S; Anderson RA; Nelson SM
    Hum Reprod Update; 2015; 21(6):698-710. PubMed ID: 25489055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Mullerian Hormone (AMH) levels in serum and follicular fluid as predictors of ovarian response in stimulated (IVF and ICSI) cycles.
    Tolikas A; Tsakos E; Gerou S; Prapas Y; Loufopoulos A
    Hum Fertil (Camb); 2011 Dec; 14(4):246-53. PubMed ID: 22088130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of baseline antral follicle count and anti-Mullerian hormone in the index stimulation cycle of IVF treatment in predicting outcome of subsequent frozen-thawed embryo transfers.
    Li HW; Lee VC; Lau EY; Yeung WS; Ho PC; Ng EH
    Gynecol Endocrinol; 2014 Jul; 30(7):490-3. PubMed ID: 24641676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers of ovarian response: current and future applications.
    Nelson SM
    Fertil Steril; 2013 Mar; 99(4):963-9. PubMed ID: 23312225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of ovarian response in women treated with corifollitropin alfa for in vitro fertilization/intracytoplasmic sperm injection.
    Polyzos NP; Tournaye H; Guzman L; Camus M; Nelson SM
    Fertil Steril; 2013 Aug; 100(2):430-7. PubMed ID: 23668992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in antral follicle counts at different times in the menstrual cycle: does it matter?
    Mavrelos D; Al Chami A; Talaulikar V; Burt E; Webber L; Ploubidis G; Yasmin E
    Reprod Biomed Online; 2016 Aug; 33(2):174-9. PubMed ID: 27184084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials.
    Nelson SM; Klein BM; Arce JC
    Fertil Steril; 2015 Apr; 103(4):923-930.e1. PubMed ID: 25624196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice.
    La Marca A; Sunkara SK
    Hum Reprod Update; 2014; 20(1):124-40. PubMed ID: 24077980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos.
    Majumder K; Gelbaya TA; Laing I; Nardo LG
    Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):166-70. PubMed ID: 20223579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
    Elgindy EA; El-Haieg DO; El-Sebaey A
    Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?
    Muttukrishna S; McGarrigle H; Wakim R; Khadum I; Ranieri DM; Serhal P
    BJOG; 2005 Oct; 112(10):1384-90. PubMed ID: 16167941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve.
    Kwee J; Schats R; McDonnell J; Themmen A; de Jong F; Lambalk C
    Fertil Steril; 2008 Sep; 90(3):737-43. PubMed ID: 17923131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.
    Arce JC; La Marca A; Mirner Klein B; Nyboe Andersen A; Fleming R
    Fertil Steril; 2013 May; 99(6):1644-53. PubMed ID: 23394782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Estimation of ovarian response using multiple predictors of ovarian reserve in women undergoing in vitro fertilization-embryo transfer].
    He Y; Xia R; Chen X; Ye D; Tang Y; Li P; Niu J; Chen S
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):216-20. PubMed ID: 23443775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Müllerian hormone and antral follicle count for prediction of ovarian stimulation response in polycystic ovary syndrome.
    El-Mazny A; Abou-Salem N
    Gynecol Endocrinol; 2013 Sep; 29(9):826-9. PubMed ID: 23855354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing four ovarian reserve markers--associations with ovarian response and live births after assisted reproduction.
    Brodin T; Hadziosmanovic N; Berglund L; Olovsson M; Holte J
    Acta Obstet Gynecol Scand; 2015 Oct; 94(10):1056-63. PubMed ID: 26184379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of ovarian reserve markers in IVF clinical practice: a national consensus.
    La Marca A; Ferraretti AP; Palermo R; Ubaldi FM
    Gynecol Endocrinol; 2016; 32(1):1-5. PubMed ID: 26531067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.